The American Association of Clinical Endocrinologists (AACE) proudly showcased their new “comprehensive algorithm” for diabetes treatment at their 22nd Annual Conference in Phoenix, AZ, at the beginning of May, replacing their previous algorithm that’s been in place since 2009.
Wait, an algorithm? No, not the technology software kind. Rather, this “algorithm” is a set of complex guidelines for doctors that, according to the AACE, “considers the whole patient, the spectrum of risks and complications for…
Read more »
More than 1,400 physicians gathered in Phoenix, AZ, last week for the 22nd Annual Scientific and Clinical Congress of the American Association of Clinical Endocrinologists (AACE). Our correspondent Wil Dubois was embedded with the “troops” covering the week-long convention, and files this report on the highlights that jumped out at him.
(In a separate article coming soon, he’ll also report on AACE’s just-announced new treatment “algorithm,” their official alternative to the American Diabetes Association’s diabetes…
Read more »
By
AmyT on
April 22, 2013
Two weeks ago today for Spring Break I was in gorgeous, palm-studded Santa Barbara, CA. And what does a diabetes technology geek like me do on vacation? Visit the local research clinic, of course!
Lucky for me, the Sansum Diabetes Research Institute in Santa Barbara (home to the legendary Drs. Lois Jovanovic and Howard Zisser) just happened to be running a clinical trial they were calling “Party Study 2.” I am not making this up.…
Read more »
What if someone said that you — someone with type 1 diabetes — could take a pill and your insulin requirements would not only drop, but they might be eliminated completely? Would you think they were crazy, or maybe confusing you with a type 2?
Well, it may not be a matter of sanity or misunderstanding. We might not be talking about a “magic pill” to make your diabetes disappear, but the early stages of…
Read more »
Yesterday we published the first half of our comprehensive behind-the-scenes interview with Joslin Diabetes Center CEO John Brooks III — who by the way took part in the 2012 DiabetesMine Innovation Summit.
Today, we continue talking with John, learning more about the legendary center, and digging into all the current ‘hot buttons’ in diabetes innovation and care:
DM) How much of Joslin’s focus is pure research?
JB) About 40% of our total focus is…
Read more »
